Health Nov 06 The potential impact of lowering the cost of weight loss drugs By William Brangham, Jackson Hudgins, Jenna Bloom
Health Oct 16 States are showing progress in reducing obesity, new report finds Cuts to federal staff and programs that address chronic disease could endanger that progress, according to a new report released Thursday. By JoNel Aleccia, Associated Press
Health Apr 14 Pfizer abandons potential obesity treatment pill The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped taking the treatment. By Tom Murphy, Associated Press
Health Mar 05 Novo Nordisk cuts Wegovy prices, following Eli Lilly on Zepbound The new monthly price of $499, down from $650, takes effect immediately. By Associated Press
Health Feb 12 Study suggests obesity drugs could help with alcohol cravings A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol. By Carla K. Johnson, Associated Press
Jan 15 Obesity won’t be solely defined by BMI under new plan for diagnosis by global experts By JoNel Aleccia, Associated Press Under recommendations released Tuesday night, obesity would no longer be defined solely by BMI, a calculation of height and weight, but combined with other measurements, such as waist circumference, plus evidence of health problems tied to extra pounds. Continue reading
Jan 02 Watch 6:00 As weight loss drug demand soars, physician outlines effectiveness and potential downsides By William Brangham, Jackson Hudgins, Hamada Hanoura For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are highly effective, they also come… Continue watching
Oct 26 Watch 8:07 Why more doctors are treating children and adolescents with weight loss drugs By Ali Rogin, Satvi Sunkara Physicians are increasingly using weight loss drugs to treat obesity, diabetes and other chronic conditions in young patients. In the last three years, the number of people between the ages of 12 and 25 using drugs like Wegovy and Ozempic… Continue watching
Sep 24 Watch 3:57 Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy By William Brangham, Courtney Norris, Ryan Connelly Holmes Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker’s CEO appeared on Capitol Hill Tuesday to face… Continue watching
Sep 24 Obesity rates hold steady, but severe obesity is on the rise By JoNel Aleccia, Associated Press Experts say preventing obesity in the first place is key, starting in early childhood. Continue reading